Products / Services
  • Products / Services
  • Companies
  • Buy Leads
Post Buy Requirement

Iclusig 15 mg

Listing ID #5153751

50,000 / Bottle
Get Latest Price
  • MOQ 1 0
  • ConditionNew
  • Blood cancer medicineCml medicine
  • Supply Type Manufacturer, Exporter, Supplier
  • Preferred Buyer Location All over the world

Ponatinib is an oral drug developed by ariad pharmaceuticals for the treatment of chronic myeloid leukemia and philadelphia chromosome–positive acute lymphoblastic leukemia. It is a multi-targeted tyrosine-kinase inhibitor
View More Details
Send Enquiry

Company Information

  • Member Since 5 Years
  • Nature of Business Retailer

Ask for more detail from the seller

Contact Supplier

Product Details no_img_icon

Ponatinib is an oral drug developed by ariad pharmaceuticals for the treatment of chronic myeloid leukemia and philadelphia chromosome–positive acute lymphoblastic leukemia. It is a multi-targeted tyrosine-kinase inhibitor


Additional Information

  • Payment Terms Western Union,
  • Packaging Details 30tabs/bottle
  • Delivery Time same day
Tell us your Buy Requirement to Get Instant Response
Tell us what you need?

By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

Looking for iclusig 15 mg?

Quantity
Seller Contact Details
Waiting for permission
To search by voice, go to your browser settings and allow access to microphone

Allow microphone access to search with voice